Replies to post #268575 on Avid Bioservices Inc (CDMO)

[Chip 1]

So ENTDOC, you are still cautiously optomistic?

[JamesGMS]

Hello again Ent, re your response excerpted in relevant part below:

Hi James. . . . . If Bavi prolongs life a few days, weeks, or months in lung cancer patients, who am I to say how much an individual or society should pay for that. Is the increased survival with Bavi, which could be more of a statistical event than a real-life improvement, worth the price? Insurance companies are probably not going to buy it. Would it be "standard of care", and everyone would get it? Doubtful. . . . .

Ent, again we are mostly in agreement - nothing we're discussing at the moment could in any way be regarded as a cure for advanced lung cancer. But nonetheless, our monitized system of health care is right now paying enormous amounts for just "a few days, weeks, or months" of additional survival in advanced lung cancer patients.

Let me make a little substitution to your statement as follows:

If Opdivo prolongs life a few days, weeks, or months in lung cancer patients, who am I to say how much an individual or society should pay for that. Is the increased survival with Opdivo, which could be more of a statistical event than a real-life improvement, worth the price? Insurance companies are probably not going to buy it.

So I repeat my question and your answer from last March.

So, my question, and once again fully agreeing with you that NOTHING at this point truly constitutes a "valid treatment for advanced lung cancer" - what would your response be if - after reviewing all of the data - Dr. Garnick can show the FDA that the Treatment Arm in Sunrise was showing an MOS of 14 months or greater?

In our incremental world - how could such a result be ignored?

As always, thanks for your thoughts and contributions.

James

James, thank you for your learned response. Yes, I think if the Bavi arm proved to have a MOS of 14 months it should be approved.

James